 | ASCO 2013: Highlights in Hematologic Malignancies CME, CPE, CNE Christopher R. Flowers, MD; Stuart L. Goldberg, MD; Susan M. O’Brien, MD; Noopur Raje, MD; Donna Reece, MD, Neil P. Shah, MD, PhD; Andrew Zelenetz, MD, PhD | |
| Release Date: June 20, 2013 Expiration Date: June 20, 2014 | ||
Clinical experts discuss key findings relative to new and emerging treatments for chronic lymphocytic leukemia, chronic myeloid leukemia, multiple myeloma, acute myeloid leukemia, and lymphoma. Provided by MediCom Worldwide, Inc. This activity is supported by educational grants from Bristol-Myers Squibb and Genentech Corporation. | ||
| BeginView Only, No Credit | ||
 | ASCO 2013: Highlights in Prostate Cancer CME, CPE, CNE Tomasz M. Beer, MD; Daniel P. Petrylak, MD; A. Oliver Sartor, MD | |
| Release Date: June 19, 2013 Expiration Date: June 19, 2014 | ||
Join Drs. Beer, Petrylak, and Sartor in discussions on important clinical advances in multiple myeloma with world-leading clinical experts in this field from the 2013 ASCO annual meeting. Provided by MediCom Worldwide, Inc. This activity is supported by an educational grant from Teva Pharmaceuticals. | ||
| BeginView Only, No Credit | ||
 | Advancements in Lung Cancer: Highlights of the 2013 ASCO Annual Meeting CME, CPE, CNE Laura Q. Chow, MD; Ramaswamy Govindan, MD; H. Kim Lyerly, MD; Giorgio V. Scagliotti, MD, PhD | |
| Release Date: June 19, 2013 Expiration Date: June 19, 2014 | ||
In this educational activity, clinical experts discuss key findings relative to new, emerging, and novel approaches to immunotherapy and targeted therapy at the 2013 ASCO meeting. This program will focus on the latest data, on what the data means in the clinical setting, and how clinicians may effectively incorporate this information to improve patient care, and ultimately, patient outcomes. Provided by MediCom Worldwide, Inc. This activity is supported by an educational grant from Bristol-Myers Squibb | ||
| BeginView Only, No Credit | ||